Alfa Cytology has announced RDC development services supported by In Vivo studies in radiopharmaceuticals.   Alfa Cytology, a leading-edge biotech company engaged in cancer research, has released its services on robust RDC (Radionuclide Drug Conjugate) development technical support for radiopharmaceuticals. The services are specifically designed to...